Marcia B. Aguila
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Tirzepatide reverses hypothalamic inflammation, cellular stress, and neuropeptide imbalance in metabolic-menopausal dysfunction.
Journal: Brain research
Published: November 13, 2025
Tirzepatide counteracts brown adipose tissue whitening, inflammation, and mitochondrial dysfunction in estrogen-deficient obese diabetic mice.
Journal: Life sciences
Published: October 05, 2025
Tirzepatide attenuates estrogen deficiency-induced metabolic dysfunction-associated steatotic liver disease progression by reducing steatosis, inflammation, and fibrosis in obese-diabetic mice.
Journal: Menopause (New York, N.Y.)
Published: June 23, 2025
Metabolic adaptations and dietary preferences in mice exposed to ketogenic and high-fat high-sucrose diets.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: April 21, 2025
Excessive dietary saturated fat or fructose and their combination (found in ultra-processed foods) impair mitochondrial dynamics markers and cause brown adipocyte whitening in adult mice.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: January 08, 2025
Tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), positively impacts the altered microbiota of obese, diabetic, ovariectomized mice.
Journal: Life sciences
Published: September 28, 2024
Melatonin-Supplemented Obese Female Mice Show Less Inflammation in Ovarian Adipocytes and Browning in Subcutaneous Adipocytes.
Journal: Cell biochemistry and function
Published: September 17, 2024
Tirzepatide, a dual receptor agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1, enhances β-cell survival and maintenance markers in obese diabetic ovariectomized mice.
Journal: Diabetes, obesity & metabolism
Published: August 08, 2024
The dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist tirzepatide effects on body weight evolution, adiponectin, insulin and leptin levels in the combination of obesity, type 2 diabetes and menopause in mice.
Journal: Diabetes, obesity & metabolism
Published: May 26, 2024
Principal components analysis on genes related to inflammasome complex and microglial activation in the hypothalamus of obese mice treated with semaglutide (GLP-1 analog).
Journal: Brain research
Published: March 04, 2024
Last Updated: 09/26/2026